Janel Corporation reported significant financial growth in its latest quarterly filing, with total revenues reaching $67.5 million for the three months ended June 30, 2026, a 37.4% increase from $49.1 million in the same period last year. For the nine months ended June 30, 2026, revenues totaled $181.0 million, up 19.7% from $151.2 million in the prior year. The growth was primarily driven by contributions from recent acquisitions, which added approximately $8.4 million and $20.4 million to revenues for the respective periods. The Logistics segment, in particular, saw a notable increase in revenue, reflecting higher demand and improved freight rates.
The company's gross profit for the quarter was $21.5 million, compared to $16.1 million a year earlier, while gross profit for the nine-month period increased to $58.2 million from $47.8 million. This resulted in a gross profit margin of 31.9% for the quarter, up from 32.8% in the previous year, indicating a slight decline in profitability despite the revenue increase. Operating income also improved, reaching $3.6 million for the quarter and $6.2 million for the nine months, compared to $1.9 million and $5.3 million, respectively, in the prior year.
Strategically, Janel has been active in expanding its portfolio through acquisitions. Notably, the company completed the acquisition of an antibody product line from BioPorto A/S for $10 million in April 2026, which is expected to enhance its Life Sciences segment. Additionally, Janel acquired a majority stake in Rubicon Technology, which has been consolidated into its financials since October 2025. These acquisitions are part of Janel's strategy to bolster its market presence and diversify its offerings across its three business segments: Logistics, Life Sciences, and Manufacturing.
Operationally, Janel's Logistics segment reported revenues of $61.1 million for the quarter, a 41.3% increase year-over-year, while the Life Sciences segment generated $3.9 million, reflecting a 10.5% increase. The Manufacturing segment, however, saw a slight decline in revenues for the nine-month period, totaling $6.9 million compared to $7.2 million in the previous year. The company’s total assets increased to $192.0 million as of June 30, 2026, up from $170.8 million a year earlier, driven by higher cash reserves and intangible assets.
Looking ahead, Janel Corporation remains focused on leveraging its acquisitions to drive organic growth and enhance shareholder value. The company anticipates continued revenue growth from its Logistics segment, supported by favorable market conditions and strategic investments. However, management has acknowledged potential challenges, including increased operational costs and market competition, which could impact future profitability.
About JANEL CORP
Janel Corporation is a diversified holding company with subsidiaries in logistics, life sciences, and manufacturing. It provides cargo transportation management, manufactures research reagents and antibodies, and produces industrial mixing equipment. Serving global markets, it focuses on strategic acquisitions, operational efficiency, and talent retention to create long-term shareholder value across its established business segments.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov